NeuroOne Medical Technologies Corporation NMTC
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -10.40% | -45.05% | 11.20% | -7.88% | 33.90% |
| Total Depreciation and Amortization | -21.67% | -8.40% | 1.87% | -3.45% | 1.52% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 100.00% |
| Total Other Non-Cash Items | -105.76% | 129.55% | -81.55% | 2,040.57% | 114.87% |
| Change in Net Operating Assets | 277.22% | 116.61% | -182.80% | -849.37% | -103.14% |
| Cash from Operations | 18.58% | 57.36% | -104.22% | -4.25% | -2,508.73% |
| Capital Expenditure | 48.83% | 5.64% | -284.91% | 75.63% | -1,259.38% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 48.83% | 5.64% | -284.91% | 75.63% | -1,259.38% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -46.45% | 284.40% | -- | -100.00% | 2,122.22% |
| Repurchase of Common Stock | 94.74% | -1,588.89% | -28.57% | 20.00% | 96.73% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -132.86% | 107.19% | -1,472.12% |
| Cash from Financing | -43.41% | 312.45% | 120.60% | -99.19% | 3,255.02% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.16% | 74.82% | -104.78% | -121.87% | 3,514.52% |